| Name | Title | Contact Details |
|---|
Christian Health Care Center (CHCC) has been fostering health, healing and wellness in northern New Jersey for more than 100 years. Since its inception, CHCC has grown to offer the most complete continuum of senior living, elder-care, short-term rehabilitation, and mental-health services available on any campus in the area, and serves as a vital source of services and information for clients, residents, patients, consumers, and their sponsors. Our commitment to caring begins with recognizing the intrinsic value of all individuals and helping each person reach his or her highest potential for health, healing, and wellness. In so doing, we seek not only to meet each person`s physical needs, but also to nurture emotional and spiritual well-being. Situated on 78 acres overlooking the Ramapo Mountains, CHCC is a non-profit organization that serves all people, regardless of race, sex, or religion. CHCC has expanded to meet the changing needs of the community and continues to offer care in a compassionate and loving environment consistent with the Christian values upon which we were founded. Senior Life Services include: Independent living (Wyckoff and Wayne), Supportive senior living, Adult day services (Wyckoff and Wayne), Assisted living Memory support, Skilled nursing, Behavior management. Short-term Rehabilitation: Post-acute care including rehabilitation therapy and skilled nursing. Mental-Health Services include: Inpatient psychiatric hospital, Short-term partial-hospitalization program, Outpatient counseling for people of all ages. The Vista: An independent-living community for active adults age 62 and over.
Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.
Levo Usa Inc is a Peachtree City, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.
Real-time PCR testing for everyone Watch the video Amplifying human potential through real-time PCR It all starts with a single sample. Add chemistry, heat, and light to make the fragments of a single virus visible by amplification up to a billion fold...